Care-Tech Laboratories, Inc. introduces two new products:
and
1-800-325-9681 Fax (314) 772-4613
St. Louis, January 1996 - Care-Tech's new technology in surgical scrub prep, TECHNI-CARE has proven to be 99.99% effective against gram + and gram - bacteria in only 30 seconds without dermal irritation. TECHNI-CARE is the first non-toxic, microbicide in the history of chemistry. This product's patent has been approved on the 14 counts of new technology in one formulation. Exceptionally mild formulation aids in healing hands abused by harsh, toxic chemicals. Apply directly to surgical sites for microbiologically "cleaner" skin, prior to and after surgical procedures. Use directly on skin areas for IV site maintenance. TECHNI-CARE offers the alternative to the use of topical antibiotics as well as providing the means of halting the spread of nosocomial infection in healthcare environments. TECHNI-CARE has proven bactericidal activity against streptococcus, staphylococcus aureus, pseudomonas aeruginosa, e. coli, MRSA, and Candida Albicans.
TECHNI-CARE has proven safe, non-toxic, and with no contraindications in usage. No damage to fibroblast cells, and no cyto-toxicity is documented. Product is capable of penetrating dermal walls, providing sustantivity of microcidal action ( depth of penetration is currently undetermined). Reduces pre-op and surgical degerming time by minimum of 50% time and cost to U.S. healthcare institution.
Use effectively for debriding of wounds or as an antiseptic treatment for lacerations and abrasions. Excellent for treatment of diabetic foot ulcers or to decontaminate chronic wounds and accelerate wound healing.
Will not irritate or stain the skin, linens, or equipment. Eliminates the problem of skin burning or "pooling" in lengthy surgical procedures. TECHNI-CARE can be used in total body bathing for a maximum infection control prior to invasive procedure, in Intensive Care Units or for general anti-infective protocols throughout all healthcare environments to protect healthcare workers.
TECHNI-CARE has recently undergone testing to determine its efficacy against the Mycobacterium Bovis TMC 1028 (Tuberculosis). TECHNI-CARE inhibits the growth of T.B. from 1 minute through 240 minutes as proven in in-vitro suspension testing. TECHNI-CARE is the first skin preparation to undergo a test of this nature which documents properties of inhibition on the tuberculin organism.
This product is available in 8 oz. Bottles, 16 oz. Bottles, 12 oz. Pumpettes, 32 oz. Foot pumps, gallons and peel packs for hospital usage as well as 20 ml disposable packets for convenience in IV site maintenance, for home health care personnel, degerming purposes, and for post-operative wound cleansing.
Matrix MICROCLYSMIC Gel New Technology - Topical Treatment for tissue trauma. Care-Tech Laboratories has introduced a revolutionary new approach in the treatment of tissue trauma, 3rd degree burns, radiation irritation, mechanical injuries, and chronic wound therapy. This new technology modifies the endothermic properties of the tissue to reduce surface temperatures 10 degrees to 15 degrees in the first 10 minutes after application. This heat reduction capacity is achieved by molecular transfer with the air.
Matrix Microclysmic Gel is bacteriostatic and modulates the osmotic pressure of a wound by the timed release of moisture. The new gel promotes and accelerates cellular regeneration by replicating the natural fibro-connective template and promoting fibroblastic activity, the precursor of collagen formation.
The fibron network maintains homeostasis via the product's bio-chemical process. By the addition of an analog of extracellular matrix, studies indicate the possible reduction of hypergranulation, scarring, and hypercontracture. Studies also indicate a dramatic increase in both the extensibility and flexibility of human skin with the addition of glycosaminoglycan chemistry.